Share

Pharmacist reviewing patient care options, representing SaveWay Compounding Pharmacy Delaware guide

SaveWay Compounding Pharmacy Delaware: The 2026 Myonex Guide

Introduction: Why SaveWay’s Story Is More Complicated Than “Delaware’s Only Sterile Compounding Pharmacy”

People searching for “SaveWay compounding pharmacy Delaware” usually fall into one of a few groups. Some are existing patients refilling bioidentical hormone replacement therapy (BHRT), pediatric formulations, or veterinary prescriptions. Others are prospective patients or referring providers. Many simply want to confirm that the pharmacy is still operating the way they remember.

Most of the information available online, including SaveWay’s own website and many directory listings, repeats the same claim: SaveWay is Delaware’s only sterile compounding pharmacy. What those sources rarely mention is that in April 2024, SaveWay was acquired by Myonex, a global clinical trial supply company.

This guide offers a transparent, fact-based walkthrough of four topics:

  • SaveWay’s history and service lines
  • The Myonex acquisition and its clinical-trial focus
  • Documented 2025 and 2026 patient service complaints
  • An open question about PCAB accreditation

The guide closes with a verified, PCAB-accredited alternative, Nationwide Compounding Rx®, for Delaware patients and providers concerned about continuity of care. This is an informational comparison. It does not claim that SaveWay has closed or stopped serving patients.

SaveWay Compounding Pharmacy: Company Background

Some baseline facts help readers unfamiliar with SaveWay understand the acquisition and what it may mean.

Founding and Growth (2001-2024)

SaveWay Compounding Pharmacy is headquartered at 31 Albe Drive, Newark, DE 19702, and was founded in 2001. The pharmacy’s own website describes its growth this way: “We have come a long way in twenty years, growing into the only Non-Sterile and Sterile compounding pharmacy in the state of Delaware.”

SaveWay also serves institutional clients alongside retail patients. Federal contracting records listed on GovTribe show the pharmacy is a vendor to the Veterans Health Administration’s VISN 4 network, which covers Delaware, Maryland, Pennsylvania, and Virginia. Under that arrangement, SaveWay provides offsite compounding to VA medical facilities, indicating a significant government business line operating alongside the community pharmacy.

Services Offered Before the Acquisition

Historically, SaveWay has offered sterile and non-sterile compounding for both humans and pets. Its service lines have included:

This is the service menu that current and prospective patients may expect to remain fully available today.

The 2024 Myonex Acquisition: What Actually Changed

The acquisition is the most significant development in SaveWay’s recent history. It is also the detail most often missing from local directories and listings.

Who Is Myonex?

Myonex is a global clinical trial supply company based in Horsham, Pennsylvania. In April 2024, Myonex completed its acquisition of SaveWay. The pharmacy now operates as “SaveWay Compounding Pharmacy, a Myonex company.”

Myonex confirmed the deal in its own press release, and the trade publication Pharmaceutical Executive (PharmExec) also reported on it.

Why Myonex Acquired SaveWay: A Clinical-Trial Supply Rationale

Myonex stated that it acquired SaveWay so it could use the pharmacy’s license to support direct-to-patient dispensing of investigational medicinal product for clinical trials. Investigational medicinal products are drugs being studied in trials, and direct-to-patient dispensing means shipping them to trial participants at home.

That is a very different business from growing retail BHRT or veterinary services. Clinical trial logistics serve pharmaceutical sponsors, while community compounding serves individual patients and their prescribers.

A release from the law firm Troutman Pepper, which advised Myonex, documents the corporate and legal details of the transaction. The firm described it as one of two back-to-back acquisitions by the company.

What SaveWay Leadership Said

SaveWay’s managing partner and pharmacist, Pradeep Chilakapati, RPh, said the deal would help SaveWay expand into clinical trials and speed up direct-to-patient services across all 50 states for trial sponsors.

That stated goal centers on sponsor and trial logistics rather than community BHRT or veterinary patients. It raises a reasonable question for longtime customers: what does this strategic shift mean for retail patients who rely on the pharmacy every month?

2025-2026 Service Disruptions: What Patients Are Actually Reporting

The following points come from publicly available reviews. They are not speculation.

Discontinued Pet Medications

Several recent reviews describe compounded pet medications being discontinued without notice. For pet owners, this is a serious problem. Many animals depend on flavored or treat-form formulations because they refuse standard pills. Losing access to a specific compounded medication without warning can interrupt treatment while the owner and veterinarian look for another source.

Unanswered Calls and Billing Issues

Other complaints describe days-long gaps with unanswered phone calls and emails. One documented case involved a cat’s refill order that was charged to a card but never shipped.

A 2026 review sourced from Nextdoor reported paying $127 per month out of pocket for compounded cyclosporine eye drops despite having insurance. This reflects a broader problem across the compounding industry, where insurance coverage for custom formulations is often limited or inconsistent. It is not unique to SaveWay.

Review Ratings Breakdown: A Mixed Public Record

Public ratings present a mixed picture:

Platform Rating Number of Reviews
Birdeye 4.4 stars 50
Yelp 3.5 stars 10
BBB A+ rating, “Not BBB Accredited” N/A

The Better Business Bureau profile lists SaveWay as not BBB Accredited while assigning it an A+ rating. These figures are data points for readers to weigh on their own, not a final verdict on the pharmacy.

The Unresolved PCAB Accreditation Question

One significant and under-reported point concerns accreditation, which at least one industry directory has flagged.

What PCAB Accreditation Actually Verifies

The Pharmacy Compounding Accreditation Board (PCAB), now administered by the Accreditation Commission for Health Care (ACHC), is one of the most demanding credentials in compounding. According to ACHC’s official PCAB materials, accreditation requires:

  • A rigorous on-site survey
  • A 36-month renewal cycle
  • Verified compliance with USP <795> (non-sterile compounding), USP <797> (sterile compounding), and USP <800> (hazardous drug handling)

Fewer than 1% of U.S. pharmacies hold PCAB accreditation. Legal analysis from Health Law Alliance notes that PCAB is a voluntary credential that verifies compounding process standards at the time of survey. Because it is voluntary, it is one of the few independent signals that a pharmacy has chosen to submit to outside review.

What the LDN Directory Listing Reveals About SaveWay

The LDN Research Trust maintains a directory of pharmacies that compound low-dose naltrexone. SaveWay’s profile there displays logos for PCCA, ACP, and NCPA, which are professional and trade organizations. However, the same profile explicitly marks “Show PCAB Logo: No.”

This suggests SaveWay may not hold independent PCAB accreditation, despite marketing itself as a sterile compounding pharmacy. It is an open question, not a confirmed fact. No reviewed source states SaveWay’s current PCAB status either way. Patients and providers should request accreditation documentation directly from any pharmacy before relying on its sterile compounding services.

Why This Matters Most for Sterile Compounding Patients

Sterile compounding covers injectables and certain BHRT formulations. These preparations carry a higher risk of contamination than creams or capsules, which makes accreditation and USP <797> and <800> compliance especially important.

Being “Delaware’s only sterile compounding pharmacy” describes local availability. It does not, by itself, verify quality standards. Patients should confirm accreditation status independently rather than accepting a marketing claim at face value.

What This Means for Different Delaware Patient Groups

The practical impact depends on what each patient needs.

BHRT Patients

Hormone therapy depends on consistent refills that are adjusted as lab results change, along with reliable turnaround. A delayed refill can cause symptoms to return. If Myonex’s clinical-trial focus shifts attention away from retail customer service, BHRT patients may notice slower communication and less flexibility with refills.

Pet Owners and Veterinary Compounding Patients

The documented discontinuation of certain pet medications is a direct continuity-of-care concern. Pet owners should confirm that a specific formulation is still available before assuming ongoing service, ideally well before the current supply runs out.

Pediatric Patients and Families

Pediatric compounding depends on precise weight-based dosing and consistent flavors that children will accept. Responsive communication matters for families, and billing or shipping delays can be especially disruptive when a child’s prescription is time-sensitive.

Referring Providers

Providers should verify current accreditation and service capacity directly with SaveWay before referring new BHRT, pediatric, or veterinary patients. Keeping a backup compounding pharmacy relationship in place is a sound way to protect continuity of care.

Nationwide Compounding Rx®: A Verified, Accredited Alternative for Delaware Patients

Nationwide Compounding Rx® is presented here as a documented alternative for human compounding needs. This section is not meant to disparage SaveWay.

PCAB Accreditation and USP 800 Compliance, Confirmed

Nationwide Compounding Rx® is PCAB-accredited and USP 800-compliant. Its quality practices include independent third-party testing and sourcing active pharmaceutical ingredients exclusively from FDA-inspected and cleared vendors. Unlike the unresolved PCAB status flagged for SaveWay, these credentials are clearly stated by the pharmacy.

Services Relevant to Delaware BHRT and Pediatric Patients

Key services include:

Nationwide Compounding Rx® focuses primarily on human compounding. Pet owners who need veterinary formulations should look for a dedicated veterinary compounding pharmacy.

Turnaround Time and Nationwide Shipping to Delaware

Nationwide Compounding Rx® ships nationwide, with Delaware among the states it serves, though availability can vary by medication type and state regulations. The pharmacy offers a 1-2 business day turnaround, with same-day pickup available for select medications.

It also runs two secure online portals:

  • Provider Portal: for submitting prescriptions, tracking orders, and contacting the pharmacy team
  • Patient Portal: for managing refills and support requests

SaveWay vs. Nationwide Compounding Rx®: A Side-by-Side Look

Factor SaveWay Compounding Pharmacy Nationwide Compounding Rx®
Ownership and focus Myonex company; acquisition aimed at clinical-trial supply Patient- and provider-focused compounding
PCAB accreditation Unresolved; LDN directory shows “Show PCAB Logo: No” Confirmed PCAB-accredited
USP compliance Not independently verified in reviewed sources USP 800-compliant
Service footprint Single Newark, DE location Ships nationwide, including Delaware (availability varies by medication and state)
Recent patient experience Documented 2025-2026 service disruptions No comparable public complaints cited
Specialty focus Human and veterinary Human: BHRT, pediatrics, pain, dermatology, sports medicine

This comparison is meant to support informed decisions. It does not declare one pharmacy better for every need. Veterinary patients, for example, still require a pharmacy that offers animal compounding.

How Delaware Patients and Providers Can Evaluate Continuity of Care

Before choosing or staying with any compounding pharmacy, patients and providers can use this checklist:

  1. Request current PCAB/ACHC accreditation documentation.
  2. Confirm USP <795>, <797>, and <800> compliance, especially for sterile products.
  3. Verify that specific formulations are currently available rather than assuming they will continue.
  4. Ask about turnaround times and communication response standards.
  5. Set up a backup pharmacy relationship for time-sensitive BHRT, pediatric, and veterinary prescriptions.

Accreditation status can be checked directly with ACHC/PCAB, so patients do not have to rely only on a pharmacy’s marketing.

Conclusion: Making an Informed Choice in a Changing Compounding Landscape

SaveWay Compounding Pharmacy has served Delaware since 2001 and has long described itself as the state’s only sterile compounding pharmacy. Its 2024 acquisition by Myonex, however, was driven by clinical-trial supply logistics. Public reviews from 2025 and 2026 describe discontinued pet medications, unanswered calls, and billing problems. A directory listing also raises an unresolved question about PCAB accreditation.

Patients and providers deserve clear, fact-based information when weighing continuity of care for BHRT, pediatric, and veterinary needs. For human compounding in Delaware, Nationwide Compounding Rx® is a verified, PCAB-accredited, USP 800-compliant option worth considering.

Ready to Explore a Verified Alternative? Connect With Nationwide Compounding Rx®

Delaware patients and referring providers can contact Nationwide Compounding Rx® through its Provider Portal or Patient Portal to discuss BHRT, pediatric, pain management, dermatology, or sports medicine compounding.

  • Phone: (480) 499-8379
  • Website: nationwidecompounding.com
  • Hours: Monday-Friday, 7:00 AM-3:30 PM

The pharmacy is PCAB-accredited and USP 800-compliant, ships nationwide including Delaware, and offers a 1-2 business day turnaround. Providers can build a dependable compounding relationship through its partnership process: Connect, Collaborate, Create, Care.

Related Posts

  • Looking beyond the directory listing, this 2026 guide breaks down Lexington's compounding pharmacy options, the accreditation standards that matter, and how new GLP-1 regulations affect local patients. Learn what to check before trusting a pharmacy with your prescription.

  • Before trusting Strive Compounding Pharmacy with a prescription or partnership, patients, prescribers, and telehealth platforms need verified facts, not marketing claims. This review examines Strive's accreditation status, FDA enforcement history, and 2025-2026 litigation using official records, then compares findings against a fully accredited alternative.

  • Asheville was just named America's #1 Wellness Town, yet its local compounding pharmacy options lack published safety credentials. This 2026 guide explains what PCAB accreditation, USP 795/797/800 compliance, and third-party testing mean when choosing a compounding pharmacy in Asheville, helping patients and prescribers make informed decisions.

  • Lumicera Specialty Pharmacy, Navitus's specialty pharmacy arm, handles standardized biologics for millions of plan members—but its formulary has hard limits. This article breaks down how Lumicera works, who it serves, and what options exist when a drug, dose, or formulation falls outside what it can fill.